Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Johnson

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brainMinjun Liu, Madison Hung, Ellen Kozlov, et al.
Annals of Neurology|June 26, 2024
Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African AmericansJames J Lah, Ganzhong Tian, Benjamin B Risk, et al.
Nature Aging|September 10, 2025
Plasma proteomic associations with Alzheimer's disease endophenotypesShiva Afshar, Eric B Dammer, Shijia Bian, et al.
Research Square|March 13, 2023
Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's DiseaseRaghav Tandon, Liping Zhao, Caroline M Watson, et al.
Science Translational Medicine|June 26, 2024
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with <i>APOE</i> ε4 and atomoxetine treatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Research Square|January 23, 2024
Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer's diseaseValborg Gudmundsdottir, Elisabet Frick, Valur Emilsson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Proteomic Network Analysis of Alzheimer's Disease Cerebrospinal Fluid Reveals Alterations Associated with <i>APOE</i> ε4 Genotype and Atomoxetine TreatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Brain Communications|April 14, 2025
Stratifying risk of Alzheimer's disease in healthy middle-aged individuals with machine learningRaghav Tandon, Liping Zhao, Caroline M Watson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Serum proteomics reveals <i>APOE</i> dependent and independent protein signatures in Alzheimer's diseaseElisabet A Frick, Valur Emilsson, Thorarinn Jonmundsson, et al.
Nature Neuroscience|February 4, 2022
Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA levelErik C B Johnson, E Kathleen Carter, Eric B Dammer, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brainMinjun Liu, Madison Hung, Ellen Kozlov, et al.
Annals of Neurology|June 26, 2024
Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African AmericansJames J Lah, Ganzhong Tian, Benjamin B Risk, et al.
Nature Aging|September 10, 2025
Plasma proteomic associations with Alzheimer's disease endophenotypesShiva Afshar, Eric B Dammer, Shijia Bian, et al.
Research Square|March 13, 2023
Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's DiseaseRaghav Tandon, Liping Zhao, Caroline M Watson, et al.
Science Translational Medicine|June 26, 2024
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with <i>APOE</i> ε4 and atomoxetine treatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Research Square|January 23, 2024
Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer's diseaseValborg Gudmundsdottir, Elisabet Frick, Valur Emilsson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Proteomic Network Analysis of Alzheimer's Disease Cerebrospinal Fluid Reveals Alterations Associated with <i>APOE</i> ε4 Genotype and Atomoxetine TreatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Brain Communications|April 14, 2025
Stratifying risk of Alzheimer's disease in healthy middle-aged individuals with machine learningRaghav Tandon, Liping Zhao, Caroline M Watson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Serum proteomics reveals <i>APOE</i> dependent and independent protein signatures in Alzheimer's diseaseElisabet A Frick, Valur Emilsson, Thorarinn Jonmundsson, et al.
Nature Neuroscience|February 4, 2022
Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA levelErik C B Johnson, E Kathleen Carter, Eric B Dammer, et al.
Pageof 21